{"@id":"https://bioecon.ru/technology/nad-precursors-nmn-nr/","@type":"Technology","cluster":"specialty-fine-chem","formats":{"html":"https://cn.bioecon.ru/technology/nad-precursors-nmn-nr/","json":"https://cn.bioecon.ru/api/v1/technology/nad-precursors-nmn-nr/index.json"},"id":"nad-precursors-nmn-nr","industries":["longevity"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/longevity/"],"suppliers":["https://bioecon.ru/companies/abinopharm/","https://bioecon.ru/companies/geneharbor/","https://bioecon.ru/companies/shenzhen-hygieia-biotech/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/mirailab-bioscience/","https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/bioviva/","https://bioecon.ru/companies/sustenir/","https://bioecon.ru/companies/momo-keto/"]},"maturity":7,"name":"用于健康老龄化的NAD+前体（NMN、NR）","regions":["us","eu","cn"],"risk":"medium","section":"technology","sector":"biochem-industrial","sources":[{"date":"2026-11-09","entity":"food.ec.europa.eu","kind":"official","urls":["https://food.ec.europa.eu/document/download/31340468-4f9b-4a31-b2db-e4238a20644e_en?filename=novel-food_sum_ongoing-app_2024-27111.pdf\u0026prefLang=nl"]},{"date":"2026-11-09","entity":"pmc.ncbi.nlm.nih.gov","kind":"research","urls":["https://pmc.ncbi.nlm.nih.gov/articles/PMC11279976/"]},{"date":"2026-11-09","entity":"abinopharm.com","kind":"web","urls":["https://abinopharm.com/nutraceuticals/nmn"]}],"stages":[{"n":1,"title":"选择工艺"},{"n":2,"title":"控制纯度"},{"n":3,"title":"核查各市场"}],"summary":"酶法与生物合成NMN作为NAD+前体已商业化规模销售；疗效、剂量与长期安全性尚未确立，监管批准仍在变化。","url":"/technology/nad-precursors-nmn-nr/","verified":"2026-11-09"}